View Clinical Trial (Medical Research Study)
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration - NCT00877032-84106(Clinical Trial 282698)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Salt Lake City |
|
State:
|
|
UT |
| Zip Code: |
|
84106 |
| Conditions: |
|
Age-Related Maculopathy - Age-Related Maculopathies - Eye Diseases - Retinal Degeneration - Macular Degeneration |
| Purpose: |
|
The purpose of this study is to determine the safety and tolerability of RN6G in patients
with dry, age-related macular degeneration.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Be of non-childbearing potential.
- Diagnosis of dry AMD as defined by the Age-Related Eye Disease Study (AREDS, 2005),
including uni- or multi-focal GA, without foveal involvement.
- BCVA of 20/320 or better in the worst eye.
Exclusion Criteria:
- Diagnosis of exudative (wet) AMD, with subretinal or choroidal neovascular lesions.
- Diagnosis or history of Alzheimer's disease, dementia or neurodegenerative disorders.
- Diagnosis or recent history of clinically significant cerebrovascular disease.
- Uncontrolled hypertension.
- Uncontrolled Type 1 or Type 2 diabetes mellitus. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
December 30, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|